Fully Diluted Equity definition

Fully Diluted Equity means, at any time, the number of Ordinary Shares on an as-converted and fully-diluted equity basis, as determined pursuant to the treasury method in accordance with GAAP.

Split View

AI-Powered Contracts

Draft, Review & Redline at the Speed of AI

Get StartedSchedule a Demo

Fully Diluted Equity means, at any time, the number of Shares on an as- converted and fully-diluted equity basis, as determined pursuant to the treasury method in accordance with, as the case may be (but applied consistently throughout the periods involved), (i) Hong Kong Accounting Standards, (2) United States generally accepted accounting principles set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statement and pronouncements of the financial Accounting Standards Board, or (iii) in such other statements by such other entity as have been approved by a significant segment of the accounting profession that are in effect from time to time.

Fully Diluted Equity means the issued and outstanding shares of the Company’s Common Stock, determined on a fully-diluted, as-converted basis as of the date of grant of the applicable stock options, inclusive of all allocated and unallocated shares authorized to be issued under the Equity Incentive Plan.

Examples of Fully Diluted Equity in a sentence

• Immediately after the Effective Time, as a result of the issuance of the Merger Share Consideration, the Merger Option Consideration, the ▇▇▇▇▇ Shares and the Wesser Shares, Proman, ▇▇▇▇▇ and ▇▇▇▇▇▇ will own, in the aggregate, 50% of the Fully Diluted Equity of PDN.

• Notwithstanding the above, if the Executive’s performance exceeds expectation, but does not reach the specified share price hurdle noted above, the Board will not unreasonably withhold the additional stock options grant to maintain her Fully Diluted Equity position at a minimum of 5%.

• If the Company closes an offering of its equity securities at a price per share of the Company’s Preferred Stock of at least $3.50, and the Executive is actively employed by the Company on the date of such closing, the Company shall grant the Executive an additional stock option (“Second Additional Option”) to purchase Shares representing 1% of the Company’s Fully Diluted Equity, taking into account the securities issued in the applicable offering), after giving effect to such grant.

• The shares underlying Option 4 are intended to represent a one percent (1.0%) ownership interest in the Company as of the date hereof (based on the number of shares of Fully Diluted Equity of the Company as of the date hereof, after giving effect to the issuance of Option 4).

• On the Effective Date, Cytek shall issue to BD 1,565,698 shares of Common Stock (the “Shares”) which shall represent no less than [***] percent ([***]%) of Cytek’s Fully Diluted Equity (the “Initial Equity Grant”), calculated after taking into account any adjustments to the Conversion Price (as defined in the Charter) of any series of Preferred Stock (as defined in the Charter) in connection with the issuance of the Initial Equity Grant, pursuant to Article IV.B, Section 4 of the Charter.

More Definitions of Fully Diluted Equity

Fully Diluted Equity means, at any time, the number of Ordinary Shares on an as-converted and fully-diluted equity basis, as determined pursuant to the treasury method in accordance with United States generally accepted accounting principles set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or in such other statements by such other entity as have been approved by a significant segment of the accounting profession that are in effect from time to time, as codified and described in FASB Statement No. 18, the FASB Accounting Standards Codification and the Hierarchy of Generally Accepted Accounting Principles, and applied consistently throughout the periods involved.

Fully Diluted Equity means all outstanding shares of Common Stock of Company and all other shares of Common Stock that may be issued by Company upon the exercise, conversion or exchange of all rights, options, warrants or other securities convertible into or exchangeable for shares of Common Stock (including the Convertible Preferred Stock and the Warrant), whether or not such rights, options, warrants or other securities are then vested, convertible or exercisable.

Fully Diluted Equity means, with respect to any Person on any given date, the number or percentage of the outstanding common stock or other equity securities of such Person on such date, after giving effect to (i) the exercise of all outstanding options, warrant or other securities or purchase rights entitling the holder to acquire shares of common stock or other equity securities of such Person, and the (ii) conversion into common stock or other equity securities of such Person of all outstanding notes, debentures, preferred stock or other securities convertible into such common stock or equity securities.

Fully Diluted Equity means on any date of exercise, the Shares plus all other shares in the capital of the Company which would arise on the exercise in full of all rights (whether or not contingent and assuming full performance linked rights) to subscribe for Shares (including under this Agreement);

Fully Diluted Equity means, as of the date of determination, all issued and outstanding shares of Common Stock (assuming conversion of all securities convertible or exchangeable, directly or indirectly, into Common Stock, including all rights, warrants and options to subscribe for, purchase or otherwise acquire Common Stock or such convertible or exchangeable securities at any time on or after the date of such determination with an exercise price equal to or less than $9.82 per share of Common Stock).

Fully Diluted Equity means (i) with respect to PharmAthene, the total number of shares of PharmAthene Common Stock then issued and outstanding, (x) including the full conversion or exercise of all then outstanding options to purchase PharmAthene Common Stock and warrants to purchase PharmAthene Common Stock, in each case, with an exercise price less than or equal to $2.50 per share of PharmAthene Common Stock, (y) excluding all then outstanding options and warrants, in each case, with an exercise price greater than $2.50 per share of PharmAthene Common Stock and (y) including all convertible securities and (ii) with respect to Theraclone, the total number of Theraclone Common Shares then issued and outstanding, including full conversion or exercise of all then outstanding options and warrants and all convertible securities.

Fully Diluted Equity all issued and outstanding (i) shares of Purchaser Common Stock, and (ii) securities convertible into or exerciseable for Purchaser Common Stock.